文章核心观点 - 文章作者及其团队专注于国际市场的长线价值投资 旨在寻找被错误定价的股票 并构建一个目标收益率约为4%的投资组合[1] - 文章提及Lightwave Logic Inc (LWLG) 指出该公司持续依赖股权市场 因此受到正反两方面反身性效应的影响[2] 相关机构与投资策略 - 作者所属的Valkyrie Trading Society是一个分析师团队 分享高确信度且冷门的发达市场投资观点 这些观点下行风险有限 并可能在当前经济环境和市场力量下产生非相关性和超额回报[2] - 该团队是纯多头投资者 并主导名为The Value Lab的投资社群 为会员提供实时更新的投资组合 24/7问答聊天 定期全球市场新闻报告 对会员个股想法的反馈 每月新交易 季度财报解读以及每日宏观观点[2]

PresentationRobert SassoonWater Tower Research LLC Hello, everybody. I'm Robert Sassoon, healthcare analyst at Water Tower Research. I have the double pleasure of hosting Kirk Huntsman, CEO of Vivos Therapeutics; and Brad Amman, the company's CFO, for this fireside chat. Vivos is a revenue stage medical technology company focused on developing and commercializing a suite of innovative diagnostic and nonsurgical treatment methods for patients suffering from breathing and sleep issues arising from certain de ...

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh. ...

Truist Securities on Tuesday started coverage on Robinhood Markets (HOOD) shares with a Buy rating on the basis of its product velocity driving sizable growth. The company's constant launch of new products and refinements of existing products are helping fuel ...

Join for a 100% Risk-Free trial and see if our proven method can help you too. You do not need to pay for the costly lessons from the market itself.Sensor Unlimited is an economist by training with a PhD, with a focus on financial economics. She is a quantitative modeler and for the past decade she has been covering the mortgage market, commercial market, and the banking industry. She writes about asset allocation and ETFs, particularly those related to the overall market, bonds, banking and financial secto ...

Alector Inc. ( ALEC ) stock has had quite a volatile year. We saw great momentum from the company as it progressed with Latozinemab through the pipeline. However, in late October, we saw a less-than-positive data readout, which droppedI hold a Master’s degree in Cell Biology and began my career working for several years as a lab technician in a drug discovery clinic, where I gained extensive hands-on experience in cell culture, assay development, and therapeutic research. That scientific foundation gave me ...

Aurinia Pharmaceuticals Inc. ( AUPH ) has had an exciting few months, with an earnings update showing continued Lupkynis growth, a competitor's drug being approved for lupus nephritis, and a request for information from the FDA. I rated AUPH aScientist and trader of biotech stock. Focus on trading around events such as trial results and NDA/BLA approvals. Also covering companies in industries regulated by the FDA. Articles present my opinion on stocks, but don't constitute investment advice.Analyst’s Disclo ...

This article is published by Terry Chrisomalis, who runs the Biotech Analysis Central pharmaceutical service on Seeking Alpha Marketplace. If you like what you read here and would like to subscribe to, I'm currently offering a two-week free trial period for subscribers to take advantage of. My service offers a deep-dive analysis of many pharmaceutical companies. The Biotech Analysis Central SA marketplace is $49 per month, but for those who sign up for the yearly plan will be able to take advantage of a 33. ...

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh. ...

The ProShares Ultra QQQ ETF ( QLD ) is a leveraged ETF that can be used to improve portfolio performance in positive momentum trends through tactical entries and with a relatively short horizon (3-6 months), while closely monitoring the macro narrativeAnalyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not rece ...